Search research articles
Contact Us
Filters
Showing results (161-170 of 172) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
The Lancet. Haematology
|
May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Benjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.
Blood Cancer Discovery
|
October 15, 2021
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
Science (New York, N.Y.)
|
May 8, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition
Zackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, et al.
Blood Advances
|
March 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy
Ran Xu, Gongwei Wu, Siobhan Rice, et al.
The Journal of Bone and Joint Surgery. American Volume
|
June 21, 2022
An Enhanced Understanding of Culture-Negative Periprosthetic Joint Infection with Next-Generation Sequencing: A Multicenter Study
Karan Goswami, Samuel Clarkson, Caleb D Phillips, et al.
The Journal of Bone and Joint Surgery. American Volume
|
May 16, 2023
The Microbiome of Osteoarthritic Hip and Knee Joints: A Prospective Multicenter Investigation
Karan Goswami, Samuel Clarkson, Craig Tipton, et al.
The New England Journal of Medicine
|
September 28, 2022
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Cancer Immunology Research
|
September 8, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
Elliott J Brea, Simon Baldacci, Neil Savage, et al.
Cancer Discovery
|
August 5, 2025
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapy
Simon Baldacci, Elliott J Brea, Francesco Facchinetti, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 172) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
The Lancet. Haematology
|
May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Benjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.
Blood Cancer Discovery
|
October 15, 2021
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
Science (New York, N.Y.)
|
May 8, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition
Zackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, et al.
Blood Advances
|
March 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy
Ran Xu, Gongwei Wu, Siobhan Rice, et al.
The Journal of Bone and Joint Surgery. American Volume
|
June 21, 2022
An Enhanced Understanding of Culture-Negative Periprosthetic Joint Infection with Next-Generation Sequencing: A Multicenter Study
Karan Goswami, Samuel Clarkson, Caleb D Phillips, et al.
The Journal of Bone and Joint Surgery. American Volume
|
May 16, 2023
The Microbiome of Osteoarthritic Hip and Knee Joints: A Prospective Multicenter Investigation
Karan Goswami, Samuel Clarkson, Craig Tipton, et al.
The New England Journal of Medicine
|
September 28, 2022
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Cancer Immunology Research
|
September 8, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
Elliott J Brea, Simon Baldacci, Neil Savage, et al.
Cancer Discovery
|
August 5, 2025
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapy
Simon Baldacci, Elliott J Brea, Francesco Facchinetti, et al.
Page
of 18